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Available online 24 October 2014Abstract Alterations in the structure of cell surface glycoforms occurring during the stages of stem cell differentiation remain
unclear. We describe a rapid glycoblotting-based cellular glycomics method for quantitatively evaluating changes in glycoform
expression and structure during neuronal differentiation of murine induced pluripotent stem cells (iPSCs) and embryonic stem
cells (ESCs). Our results show that changes in the expression of cellular N-glycans are comparable during the differentiation of
iPSCs and ESCs. The expression of bisect-type N-glycans was significantly up-regulated in neurons that differentiated from both
iPSCs and ESCs. From a glycobiological standpoint, iPSCs are an alternative neural cell source in addition to ESCs.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/4.0/).IntroductionPreviously, it was thought that the fully developed mam-
malian central nervous system (CNS) lacks significant
regenerative capacity (Ramon, 1928). However, the recent
discovery of neural progenitor cells, including neural stem
cells (NSCs), has shown a potential for overcoming this
limitation in repairing the damaged CNS (Reynolds and
Weiss, 1992; Taupin and Gage, 2002; van Praag et al., 2002).
The morphology and function of NSCs change drastically
during the course of neuronal differentiation from NSCs to⁎ Corresponding author at: Department of Orthopedic Surgery, Hokkaid
060-8638, Japan. Fax: +81 11 7066054.
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1873-5061/© 2014 The Authors. Published by Elsevier B.V. This is an ope
(http://creativecommons.org/licenses/by-nc-sa/4.0/).neurons (Nakayama and Inoue, 2006; Nakayama et al.,
2004). Despite a large number of studies aimed at clarifying
the mechanisms of neuronal differentiation, many important
questions remain unanswered.
Induced pluripotent stem cells (iPSCs) generated from
somatic cells via direct molecular reprogramming are capable
of unlimited proliferation and differentiation into multiple
types of mature cells (Takahashi et al., 2007; Takahashi and
Yamanaka, 2006). Mouse and human iPSCs are similar to theiro University Graduate School of Medicine, N15, W7, Kita-ku, Sapporo
n access article under the CC BY-NC-SA license
455Quantitative glycomics monitoring of induced pluripotent and embryonic stem cellsrespective embryonic stem cells (ESCs) in terms of morphol-
ogy, proliferation, gene expression, and teratoma formation
(Takahashi et al., 2007). It is believed that these stem
cells hold tremendous promise with regard to applications
in regenerative medicine. However, current methods for
assessing differential properties are limited in scope and a
comprehensive method that directly targets stem cells is
lacking. Development of such methodologies is an essential
prerequisite for the clinical application of iPSCs and ESCs.
Although a number of functional genomic and proteomic
studies of cellular differentiation have been conducted in
recent years (Gonnet et al., 2008; Kuramitsu and Nakamura,
2006; Watkins et al., 2008), no reliable molecular markers
have emerged that can be used to determine the quality and
differentiation status of iPSCs and ESCs. Glycans attached to
proteins (glycoproteins) and sphingolipids (glycosphingolipids)
are located at the outermost surface of the cell. Significant
alterations in the cellular glycome occur during development
and cellular differentiation (Amano et al., 2010; Kannagi
et al., 1983; Lanctot et al., 2007; Lau et al., 2007), suggesting
that glycans could serve as novel cellular differentiation
biomarkers. Unfortunately, technical difficulties have ham-
pered efforts to determine the total glycan complement of
mammalian cells and have limited the assessment of cell
type-specific glycoforms.
To overcome these methodological issues, we developed
a glycoblotting method based on a PCR-like technology that
allows for rapid and quantitative glycan analysis (Amano
et al., 2010). The majority of glycoproteins are classified
into 2 groups: those attached to an asparagine residue
through a nitrogen atom (N-glycans) and those attached to a
serine or a threonine residue (O-glycans). Cellular responses
to signals that stimulate growth or cell-cycle arrest depend
heavily on the total number of N-glycan molecules on the
surface of the cell and the degree of branching of cell
surface glycoproteins (Lau et al., 2007). Of these 2 types of
glycans, modifications of N-glycans on proteins are thought
to contribute to embryogenesis and organogenesis. However,
a full portrait of glycome diversity and the effect of cellular
glycoform structural variations on individual cell stages during
proliferation and differentiation remain unclear. Therefore,
we quantitatively monitored dynamic glycoform changes
during neuronal differentiation of mouse iPSCs and ESCs by
using this glycoblotting method.
The hypothesis of this study is that alterations in N-glycans
occur during neuronal differentiation of mouse ESC and
iPSC-derived NSCs. The objectives of this study are to
identify alterations in N-glycans and the gene expression of
an associated N-glycan biosynthesis enzyme during the course
of neuronal differentiation in mice. Additionally, we com-
pared the glycoform pattern in neuronal cells differentiated
from iPSCs or ESCs.Materials and methods
Cell culture and differentiation
NSCswere induced frommouse iPSCs and ESCs using previously
described methods (Nakayama et al., 2003; Terashima
et al., 2010). In brief, undifferentiated mouse iPSCs (Okita
et al., 2007) and ESCs (RIKEN BRC Cell Bank, Ibaraki, Japan,http://cell.brc.riken.jp) (Yagi et al., 1993) weremaintained
by periodical seeding at a clonal density of 1500 cells/6 cm
dish and grown on a feeder layer of mitotically-inactivated
(mitomycin C, Sigma-Aldrich, St. Louis, MO, http://www.
sigmaaldrich.com) mouse embryonic fibroblasts (ORIENTAL
YEAST, Tokyo, Japan, http://www.oyc.co.jp) in the presence
of 1000 U/ml of leukemia inhibitory factor (LIF, Millipore,
Billerica, MA, http://www.millipore.com) contained in the
iPSC and ESC medium. The iPSC and ESC medium consisted
of Dulbecco's modified Eagle's medium (DMEM, Sigma-Aldrich)
supplemented with 15% Knockout Serum Replacement
(Gibco, Grand Island, NY, http://www.invitrogen.com),
0.1 mM β-mercaptoethanol and 1 mM each of the non-
essential amino acids (both from Millipore).
To stimulate differentiation and proliferation, colonies of
undifferentiated iPSCs and ESCs were grown for 7–9 days
until reaching 300–500 μm in diameter, and were then lifted
from the feeder layer and transferred onto non-adherent
bacteriological dishes and cultured in astrocyte-conditioned
medium (ACM) supplemented with 20 ng/ml of recombinant
basic fibroblast growth factor (FGF-2), and 20 ng/ml of
recombinant epidermal growth factor (EGF, both from
WAKO). Colonies were then cultured for 4 days to give rise
to neural stem spheres (NSSs). The NSSs were plated onto a
Matrigel (BD Biosciences, Franklin Lakes, NJ, http://www.
bdbiosciences.com/home.jsp)-coated dish containing NSC
medium and allowed to expand for 7 days. The NSC medium
consisted of neurobasal medium (Gibco) supplemented with
2% B-27 (Gibco), 2 mM L-glutamine (WAKO), 20 ng/ml FGF-2,
20 ng/ml EGF, and 1% penicillin–streptomycin (Gibco). At
this stage, the NSSs had been transformed into circular
clusters of cells, and flat adherent cells (NSCs) had migrated
out of the clusters to the surrounding areas. After the cell
clusters were removed from the dish, NSCs were harvested by
treatment with trypsin. The harvested cells were expanded
in NSC medium and kept frozen at −80 °C in fetal bo-
vine serum (FBS, Gibco) containing 10% dimethyl sulfoxide
(Sigma-Aldrich) and preserved in liquid nitrogen. Upon thawing,
frozen cells were initially conditioned in NSC medium.
To induce neuronal differentiation, NSCs were cultured
in neuron differentiation medium (NDM). NDM consisted
of NSC medium supplemented with 50 ng/ml of brain
derived neurotrophic factor (BDNF, Regeneron Inc., Tarrytown,
NY, http://www.regeneron.com), 0.1 μM retinoic acid
(Sigma-Aldrich), 10 μM forskolin (WAKO), and 100 μM ascorbic
acid (WAKO) (Nakayama et al., 2003). To stimulate differen-
tiation of NSCs into astrocytes (Nakayama et al., 2006), the
NSC culture mediumwas changed to DMEM supplemented with
10% FBS, and 1% penicillin–streptomycin (Gibco) (astrocyte
differentiation medium, ADM). When cellular proliferation
was observed, the culture medium was changed to ADM.Primary cell culture
Cerebral cortices from C57BL/6 mice (Sankyo Labo Service
Corporation, Tokyo, Japan, http://www.sankyolabo.co.jp)
were dissected from 17-day embryos and incubated in DMEM
(Sigma-Aldrich) containing 0.25% trypsin (Gibco) for 15 min
at 37 °C. The cells were then dissociated by mechani-
cal trituration, washed with DMEM, and resuspended in
neurobasal medium supplemented with 2% B27 supplement
Figure 1 Schematic showing the basic protocol of the glycoblotting-based method for quantitative analysis of a cellular glycome
using BlotGlyco H beads.
456 M. Terashima et al.(both from Gibco), 500 μM L-glutamine, 25 μM glutamic acid
(both from Sigma-Aldrich) and 1% penicillin–streptomycin
(Gibco). The cells were then plated onto poly-L-lysine-coated
(0.1 mg/ml; Sigma-Aldrich) 60 mm plastic dishes at 1.4 × 106
cells/dish. All animal procedures were performed in accor-
dance with the Guidelines for Animal Experimentation
prepared by the Animal Care and Use Committees of Hokkaido
University.Figure 2 Establishment of iPSC- and ESC-derived NSCs. (a) Colon
derived from iPSCs. (c) NSCs generated from iPSCs. (d) Colony of u
from ESCs. (f) NSCs generated from ESCs.Immunofluorescence
Cultured cells were fixed with 4% paraformaldehyde in
phosphate buffered saline (PBS) for 15 min at room temper-
ature. After permeabilization and blocking, the fixed cells
were incubated for 60 min at room temperature with PBS
containing a primary antibody and 1% bovine serum albumin.
Primary antibodies and the dilutions used were as follows:y of undifferentiated iPSCs. (b) Neural stem sphere with NSCs
ndifferentiated ESCs. (e) Neural stem sphere with NSCs derived
Figure 3 Characterization of iPSC- and ESC-derived NSCs differentiated into neurons and astrocytes. Neuronal differentiation of
iPSC-derived NSCs (a–c) and ESC-derived NSCs (g–i). Glial differentiation of iPSC-derived NSCs (d–f) and ESC-derived NSCs (j–l).
Phase-contrast micrographs (a, d, e, j), βIII-tubulin immunodetection (b, e, h, k), and GFAP immunodetection (c, f, i, l). Scale
bars = 100 μm.
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chemicon.com) at 1:100, anti-βIII-tubulin (βIII, G7121,
Promega, Madison, WI, http://www.promega.co.jp) at
1:1000, and anti-glial fibrillary acidic protein at 1:1000
(GFAP, Z033429, Dako, Carpinteria, CA, http://www.dako.jp).
After washing, samples were incubated for 30 min at
room temperature with Cy3-conjugated goat anti-mouse
IgG (115-165-146, Jackson ImmunoResearch, West Grove, PA,
http://www.jacksonimmuno.com) at 1:10,000 and Alexa488-
conjugated goat anti-rabbit IgG (A11034, Molecular Probes,
Eugene, OR, http://probes.invitrogen.com) at 1:10,000.
Finally, digital images were captured using a fluorescence
microscope system (Carl Zeiss Axio Imager and AxioVert
with MRm camera) equipped with AxioVision software (Carl
Zeiss, Jena, Germany, http://corporate.zeiss.com).RT-PCR analysis
Total RNA was extracted from cultured cells using a Trizol
reagent (Invitrogen, Carlsbad, CA, http://www.invitrogen.
com). Aliquots of total RNA (0.5 μg) were then subjected
to cDNA synthesis using ImProm-II™ reverse transcriptase
and a random primer (both from Promega). mRNA levels
were determined with an Opticon Real-Time PCR instrument(MJ Research, Inc., Reno, NV) using sequence-specific primer
pairs as listed in Supplementary Table 1. PCR was carried out
on duplicate cDNA samples using SYBR Green Master Mix
(Finnzymes, Vantaa, Finland, http://diagnostics.finnzymes.fi),
according to the manufacturer's protocol. The relative mRNA
expression for each targeted gene was expressed as the cycle
threshold value of each gene normalized to the cycle threshold
value of the glyceraldehyde-3-phosphate dehydrogenase gene
as a housekeeping control.Extraction of N-glycans from cells
Release of total cellular N-glycans was carried out as
previously described, with minor modifications.
In brief, during differentiation, cultured stage-specific
cells were scraped from dishes in PBS containing 10 mM EDTA
and washed with PBS. Following resuspension in PBS, cells
were lysed by incubation with 1% Triton X-100 (WAKO) for
60 min on ice. The lysates were centrifuged at 15,000 rpm
for 10 min at 4 °C, and the resulting supernatants were
added to cold acetone (final concentration, 80%) to precipi-
tate proteinaceous material. After overnight incubation at −
20 °C, the precipitates were collected by centrifugation at
12,000 rpm for 15 min at 4 °C followed by serial washing with
Figure 4 Quantitative RT-PCR analysis of gene expression
during differentiation of iPSC- and ESC-derived NSCs. Expres-
sion of marker genes during differentiation of (a) iPSC- and
(b) ESC-derived NSCs. mRNA levels were normalized to the
gene showing the highest level of expression. Each value
represents the mean ± SD of five measurements from different
experiments.
458 M. Terashima et al.acetonitrile. The precipitates were then dissolved in 50 μl
of 80 mM ammonium bicarbonate containing 0.02% each
of 1-propanesulfonic acid and 2-hydroxyl-3-myristamido and
incubated at 60 °C for 10 min. The solubilized proteinaceous
material was reduced by incubation in 10 mM 1,4-dithiothre-
itol at 60 °C for 30 min, and was then alkylated by incubation
in 20 mM iodoacetamide in the dark at room temperature for
30 min. The mixture was then treated overnight at 37 °C with
400 U of trypsin (Sigma-Aldrich), after which the enzyme
was heat-inactivated by incubation at 90 °C for 10 min. After
cooling to room temperature, the N-glycans were released
from the trypsin-digested glycopeptides by overnight incuba-
tion at 37 °C with 2 U of peptide-N-glycosidase F (PNGase F,
Roche Applied Science, Penzberg, Bavaria, http://www.
roche-applied-science.com). Samples were then dried using
a SpeedVac (Thermo Fisher Scientific, Waltham, MA, http://
www.thermofisher.co.jp) and stored at −20 °C until use.Glycoblotting
Glycoblotting of N-glycans using BlotGlyco H beads (Sumitomo
Bakelite Co., Tokyo, Japan, http://www.sumibe.co.jp) was
performed according to a previously described procedure(Furukawa et al., 2008). A 250 μl aliquot of BlotGlyco H beads
(10 mg/ml suspension) was placed into a well of a MultiScreen
Solvinert filter plate (Millipore). PNGase F-digested samples
were dissolved with water and the concentration adjusted to
100 μg of protein/20 μl, after which 20 μl was applied to the
well and 180 μl of 2% acetic acid in acetonitrile (ACN) was
added. The plate was incubated at 80 °C for 45 min and total
glycans were specifically captured by the beads via stable
hydrazone bonds. The plate was washed with 200 μl of 2 M
guanidine–HCl in ammonium bicarbonate and then washed
with the same volume of water and 1% triethyl amine in
methanol (MeOH). Each washing step was performed twice.
Unreacted hydrazide functional groups on the beads were
capped by incubation with 10% acetic anhydride in MeOH
for 30 min at room temperature. The solution was removed by
vacuum and the beads were then serially washed twice with
200 μl each of 10 mM HCl, MeOH, and dioxane. On-bead
methyl esterification of carboxyl groups of sialic acids
was carried out by incubation with 150 mM 3-methyl-1-p-
tolyltriazene in dioxane at 60 °C to dryness. This process
typically required 90 min in a conventional oven. Beads
were then serially washed with 200 μl each of dioxane, MeOH,
and water. Glycans bound to the beads were subjected to
transiminization by incubation with aminooxy-functionalized
tryptophanyl arginine (ao-WR) for 45 min at 80 °C. The ao-
WR-tagged glycans were eluted by adding 100 μl of water,
and then purified using a Mass PREP™ HILIC μElution Plate
(Waters, Milford, MA, http://www.waters.com) according
to the manufacturer's instructions.Mass spectrometry
Purified N-glycans were concentrated 10-fold using a
SpeedVac (Thermo Fisher Scientific) and then mixed with
2,5-dihydroxylbenzoic acid (10 mg/ml in 30% ACN) (1:2) and
allowed to crystallize. Analytes were subjected to matrix
assisted laser desorption ionization-time of flight (MALDI-TOF)
mass spectrometry using an Ultraflex II (BrukerDaltonics,
Billerica, MA, http://www.bruker.com) mass spectrometer
operated in reflector, positive ion mode, typically summing
7000–10,000 shots until the intensity of the base peak
reached 1 × 105. N-glycan spectral peaks were picked using
FlexAnalysis ver. 3.0 software (Bruker Daltonics). Quanti-
tation was performed by normalizing the area of the
corresponding peak of each glycan to that obtained with
20 pmol of an internal standard (A2 amide glycan) (Fig. 1).
Changes in glycan expression levels were calculated as dif-
ferentiated versus undifferentiated. Glycan structures were
estimated using the GlycoMod Tool (http://web.expasy.org/
glycomod/) and GlycoSuiteDB (http://glycosuitedb.expasy.
org/glycosuite/glycodb).Statistical analyses
Quantitative data are presented as the mean ± SD (n = 5 in
each group). Statistical analyses were performed using one-
way ANOVA with Bonferroni's multiple comparison tests using
Graphpad Prism software (GraphPad, La Jolla, CA, http://
www.graphpad.com). P-values less than 0.05 were considered
significant (alpha level = 0.05).
Figure 5 MALDI-TOF/MS spectra of total N-glycans during cell differentiation. MALDI-TOF/MS spectra of total N-glycans extracted from iPSCs, iPSC-derived NSCs and neurons
differentiated from iPSC-derived NSCs (a), and ESCs, ESC-derived NSCs and neurons differentiated from ESC-derived NSCs (b) are shown. Primary neurons and astrocytes served as
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Figure 7 Quantitative analysis of N-glycans of the primary neuron. The glycoblot patterns of neurons that differentiated from iPSCs
and ESCs closely resemble that of mature primary neurons.
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Establishment of iPSC- and ESC-derived NSCs
NSCs were initially induced from mouse iPSCs and ESCs
(Fig. 2). The induced NSCs were then differentiated into
neurons and astrocytes using previously described methods
(Fig. 3) (Nakayama et al., 2003; Terashima et al., 2010).
During neuronal differentiation, the NSCs began extending
neurites after the first day of culture. Within 7 days, the
NSCs acquired a neuronal appearance, characterized by
the presence of long neurites. During glial differentiation,
the NSCs became flattened and their morphology began to
resemble that of primary cultured astrocytes.
Characterization of iPSC- and ESC-derived NSCs
differentiated into neurons and astrocytes
Immunofluorescence analysis revealed that NSC cultures
allowed to differentiate into neurons for 14 days consisted
of N60% βIII-tubulin-positive neurons and b40% GFAP-positive
astrocytes. Fluorescence microscopy analysis revealed that
NSC cultures allowed to differentiate into astrocytes for
21 days consisted of N99% GFAP-positive astrocytes (Fig. 3).
Quantitative RT-PCR analysis of gene expression
during differentiation of iPSC- and ESC-derived NSCs
Real time RT-PCR analysis showed an abundance of Oct4
mRNA, a typical genetic marker for iPSCs and ESCs, in iPSCs
and ESCs only (Fig. 4). Expression of nestin mRNA, a specific
genetic marker for NSCs, increased dramatically in both
iPSC- and ESC-derived NSCs, and decreased as the cells
further differentiated into neurons or astrocytes (Fig. 4).
Concurrently, expression of mRNAs encoding βIII-tubulin and
GFAP was markedly increased during differentiation of NSCsFigure 6 Quantitative analysis of N-glycans during neuronal and
profiling during neuronal differentiation of iPSCs (a, b) and ESCs (c,
expression. In the case of iPSCs, a total of 120 N-glycans were identif
41, 43, 51, 55, 60, 67, 72, 79 and 119) were up-regulated during th
up-regulated, there were 2 types of bisects (peak numbers 36 and 72
it was revealed that 12 glycoforms (peak numbers 17, 22, 24, 30, 3
neuronal differentiation (c). Of the 12 glycoforms that were up-regu
Glycoforms of two types that were up-regulated in iPSCs and ESCs winto neurons and glial cells, respectively (Fig. 4). Changes in
the expression of these marker genes are indicative of
successful neuronal differentiation of iPSCs and ESCs.
Monitoring N-glycomic changes associated with
neuronal and glial differentiation of iPSCs and ESCs
A glycoblotting-based quantitative glycomic analysis was
performed to characterize glycoform changes that occur
during differentiation of mouse iPSCs and ESCs into neural
cells (Fig. 5). Total N-glycans collected at each stage of
neuronal differentiation from both iPSCs and ESCs were
analyzed and identified using a combination of glycoblotting
and MALDI-TOF MS. For a total of 120 in iPSCs and 85 in ESCs,
different glycoformswere reproducibly detected andquantified
in both stem cell types (Figs. 6a, c).
Monitoring N-glycan expression during neuronal and
glial differentiation of iPSCs and ESCs
High-mannose-typeN-glycans weremajor components of both
the iPSC and ESCN-glycomes, and their expressionwas notably
altered throughout neuronal differentiation. While the ex-
pression of high-mannose N-glycans relative to total N-glycan
expression (% expression level) increased significantly during
differentiation of both iPSCs and ESCs into NSCs, the levels
of high-mannose N-glycans decreased significantly during the
differentiation of NSCs into neurons and astrocytes (p b .05)
(Figs. 6b, d).
Bisect-type N-glycans are found in the mouse brain
(An et al., 2005; Zamze et al., 1999) and reportedly play a
crucial role in neuronal differentiation (Amano et al., 2010;
An et al., 2005; Zamze et al., 1999). Our analysis showed that
expression of bisect-type N-glycans was significantly up-
regulated during neuronal differentiation of iPSCs and ESCs,
increasing from 2% and 1% to 12% and 11%, respectively, of the
total N-glycan complement (Figs. 6b, d).glial differentiation of iPSCs and ESCs. Quantitative N-glycans
d). a and c: Detail showing particular glycans with up-regulated
ied and it was revealed that 11 glycoforms (peak numbers 29, 36,
e neuronal differentiation (a). Of the 11 glycoforms that were
). In the case of ESCs, a total of 85 N-glycans were identified and
5, 37, 47, 50, 56, 57, 62 and 67) were up-regulated during the
lated, there were 2 types of bisects (peak numbers 22 and 67).
ere the same respectively.
462 M. Terashima et al.The glycoblot patterns of primary neurons differentiated
from iPSCs and ESCs closely resemble that of mature primary
neurons (Fig. 7).
Quantitative RT-PCR analysis of Mgat3 expression
during differentiation of iPSC- and ESC-derived NSCs
Mgat3 is known to transfer a GlcNAc residue to the beta-linked
mannose of the trimannosyl core of N-linked oligosaccharides
and produce a bisecting GlcNAc. Therefore, we focused on
the expression pattern of Mgat3. The results of RT-PCR
analysis of stem cell-derived neurons demonstrated a
significant up-regulation of the Mgat3 (GlcNAc-transferase
III) gene encoding a glycosyltransferase responsible for the
synthesis of bisecting GlcNAc linkages (Supplementary
Fig. 1). This result was consistent with the observed
structural changes in bisect type N-glycans determined
using the current glycoblotting technique.
Discussion
Recent neurogenesis studies and the discovery of multipotent
neural stem cells derived from the adult mammalian CNS,
including that of humans, have had a considerable influence
on potential treatments for neural injury (Gross, 2000; Ming
and Song, 2005). Although iPSCs are promising candidates as a
cell source for applications in neural regeneration (Takahashi
et al., 2007; Takahashi and Yamanaka, 2006), little is known
about the glycomic profiling of iPSCs compared with ESCs. For
the purpose of clinical applications, the biological character-
istics of iPSCs and ESCs before and after differentiation should
be identified. Therefore, we performed quantitative glycan
analysis to identify the biological difference between iPSCs
and ESCs during neuronal differentiation.
Our analysis showed that the expression pattern in
undifferentiated iPSCs was 2% bisect-type N-glycans and
60% of high-mannose N-glycans, whereas the pattern in ESCs
was different from that of iPSCs (1% of bisect-type N-glycans
and 75% of high-mannose N-glycans).
Although the HILIC–LC/MS method can directly measure
the N-glycan released from glycoproteins, its accuracy is
insufficient because this method cannot avoid capturing
small size peptides which have a hydrophobic property. Our
glycoblotting method is theoretically more accurate than
HILIC–LC/MS method because this method captures only
glycans via a chemoenzymatically specific reaction.
Tateno et al. (2011) reported a similar glycoblot pattern
in both iPSCs and ESCs using lectin arrays for cellular
characterization. Dodla et al. and Alisson-Silva et al. also
reported an alteration of glycans during cell differentiation
using lectin arrays. However, a limited number of lectins,
the proteins which recognize specific glycans, are available
with this method and they usually show broad specificity for
glycan structures (Alisson-Silva et al., 2014; Dodla et al.,
2011). Furthermore, another advantage of our method is
that it provides quantitative information.
Fujitani et al. performed a comprehensive analysis of the
cellular glycomes of human iPSCs and human ESCs, including
N-glycans, O-glycans, glycosaminoglycans, glycosphingolipid-
associated glycans, and free oligosaccharides. They identified
distinct glycoblot patterns for iPSCs and ESCs (Fujitani et al.,2013). In the present study, we report a complete portrait of
cellular N-glycan expression during an undifferentiated stage
that allows for the identification of characteristic glycotypes.
The patterns of cellular glycoforms detected using this precise
analysis were distinct, indicating that iPSCs and ESCs are
distinguishable by their glycan structures.
Although the pre-neuronal differentiation glycoblot pat-
terns were different between iPSCs and ESCs, glycoblot
patterns in iPSCs and ESCs became more similar with neuronal
differentiation. Moreover, glycoblot patterns in neurons
differentiated from iPSCs and ESCs closely resemble that of
mature neurons (Fig. 7). During neurogenesis, N-glycan
structures appear to contribute to cell–cell and cell–matrix
interactions, resulting in targeting behaviors such as cell
migration and neurite outgrowth. Therefore, N-glycans are
considered to be an important regulatory factor during
neuronal differentiation (Gu et al., 2004; Shigeta et al., 2006).
The glycoblot profiles of N-glycans revealed that the
expression of bisect-type N-glycans was significantly up-
regulated in neurons differentiating from iPSCs or ESCs.
Bisect-type N-glycans are thought to regulate neurite
outgrowth (Shigeta et al., 2006) and neuronal differentiation
(Gu et al., 2004). Amano et al. (2010) demonstrated
that both mouse embryonic carcinoma cells and ESCs
exhibited up-regulation of bisect-type N-glycans during
neuronal differentiation. These results suggest that undif-
ferentiated cells, such as embryonic carcinoma cells, iPSCs,
and ESCs, exhibit a general pattern of glycan expression
during neuronal differentiation.
Although the expression of bisect-type N-glycans during
neuronal differentiation was significantly up-regulated,
this did not occur during glial differentiation. This result
indicates that increased bisect-type N-glycan expression is
specific to neuronal differentiation. Therefore, bisecting type
N-glycans potentially represent a novel class of biomarkers for
identifying and monitoring neuronal differentiation from iPSCs
or ESCs.
The glycoblotting method is a novel option for assessing
cellular differentiation. Additionally, we evaluated the expres-
sion pattern of GlcNAc-transferase III (GnT III, Mgat3 gene), the
glycosyltranferase responsible for the synthesis of the bisecting
GlcNAc linkage, to cross-validate the result obtained using the
glycoblotting approach. As expected, GnT III was significantly
up-regulated in neurons that differentiated from iPSCs or
ESCs, whereas this did not occur during glial differentiation.
The obtained results support the contention that bisect-type
N-glycan expression is altered during neuronal differentiation
from iPSCs or ESCs. Furthermore, the expression level of GnT
III is predictive of the state of neuronal differentiation of iPSCs
or ESCs.
The limitation of this study is a lack of functional analysis
of bisect-type-N-glycans. Although bisect-type-N-glycans
and related genes (GnT III and Mgat3) are synergistically
up-regulated during the neuronal developmental process,
their function is still unknown. In terms of glycosyltransfer-
ase, it is extremely difficult to prove whether or not a
bisect-type is the cause of the differentiation. Because the
expression of Mgat3 is known to reduce cell migration and
cell proliferation (Iijima et al., 2006; Pinho et al., 2012), it is
difficult to distinguish whether the direct effect of Mgat3 or
indirect effect is due to cell density or cell–cell contact
effect. In addition, the exogenous addition of bisect-type
463Quantitative glycomics monitoring of induced pluripotent and embryonic stem cellsglycans to the media is the most simple and direct way to
prove the role of a bisect-type glycan in neuronal differen-
tiation. However, it is difficult to prove whether or not the
exogenous bisect-type glycans work similarly to endogenous
bisect-type glycans on cell membranes.
Our procedure for the measurement of glycoproteins was
more comprehensive and quantitative compared with previ-
ous methods. Therefore, we believe that our data is evidence
that bisect-type N-glycans potentially represent a novel class
of biomarkers for identifying and monitoring neuronal differ-
entiation. The functional analysis of bisect-type-N-glycans
and Mgat3 is required in the future.
In conclusion, we detected homologous changes in the
expression of N-glycans during differentiation of induced
pluripotent and embryonic stem cells. The N-glycan structures
of iPSC- and ESC-derived neurons were found to be compara-
ble to those of the primary neurons. The current analysis
indicates that bisect-type N-glycans are promising candidates
as cellular markers for identifying iPSC- and ESC-derived
neurons, although the functional role of these molecules in
the neuronal differentiation process remains unclear. In terms
of their glycoforms, iPSCs and ESCs are biologically distinct.
However, both of these undifferentiated cell types transition
to a unified glycoblot pattern during neuronal differentiation.
Therefore, iPSCs represent an alternative neural cell source,
in addition to ESCs, at least at the glycobiological level.Conclusion
In this study, we demonstrated that a significant alteration
in bisecting typeN-glycan expression occurs during the course of
neuronal differentiation from mouse iPSC- and ESC-derived
NSCs. The expression pattern of bisecting type N-glycans in
undifferentiated iPSCs was different from those of ESCs, hence
iPSCs and ESCs are glyco-structurally distinct. Moreover, during
the course of neuronal differentiation, the expression of
bisect-type N-glycans was significantly up-regulated in neurons
that differentiated from both iPSCs and ESCs. This result
suggests that bisecting type N-glycans may represent a new
class of biomarkers for identifying and monitoring the neuronal
differentiation processes. In terms of glycoforms, iPSCs and
ESCs are biologically distinct, however, both undifferentiated
cell types transition to a unified glycoblot pattern during
neuronal differentiation. Therefore, iPSCs are an alternative
neural cell source, in addition to ESCs, at least from a
glycobiological standpoint.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.10.006.Acknowledgments
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